Lipitor Diabetes


The statin Lipitor may be linked to increased risk of Type 2 diabetes, especially when used by post-menopausal women. Hundreds of lawsuits have been filed in U.S. courts that accuse Pfizer, Inc. of failing to warning patients and doctors about the potential association between Lipitor and diabetes.

Lipitor Legal Reviews

The nationwide law firm of Bernstein Liebhard LLP represents the victims of dangerous drugs and medical devices, including women who may have developed Type 2 diabetes due to their use of Lipitor. To arrange for a free review of your potential Lipitor lawsuit, please call (888) 994-5118.

Studies on Lipitor and Diabetes

Lipitor (atorvastatin) was brought to market in 1996 by the Warner- Lambert Company, which was eventually acquired by Pfizer. Before it lost patent protection, the cholesterol-lowering medication was one of the top-selling drugs in the world, generating more than $125 billion in sales. Lipitor works by preventing the liver from creating an enzyme that helps the body produce cholesterol.

Lipitor and other statins have been linked to a number of serious side effects, including muscle injury and kidney problems. Recent studies have also suggested that people who use these drugs might be more likely to develop Type 2 diabetes:

  • In 2011, a study that appeared in Journal of the American College of Cardiology suggested patients treated with high-dose Lipitor were more likely to develop the Type 2 diabetes, especially women or those with pre-existing factors for the disease.
  • In 2012, a study published in JAMA: Internal Medicine suggested that post-menopausal women who took Lipitor or other statins faced a 48 percent increased risk for developing Type 2 diabetes compared to those who did not. The study involved 153,840 non-diabetic women between the ages of 50 and 79.
  • Canadian researchers reported in 2013 that patients taking Lipitor had a 22 percent increased risk of developing diabetes compared to those taking another cholesterol-lowering medication called Pravachol.

In February 2012, the U.S. Food & Drug Administration (FDA) announced that it had ordered statin manufacturers to add new information to the drugs’ labels regarding their potential effects on blood glucose levels.

Lipitor Litigation

Hundreds of Lipitor lawsuits have been centralized in the U.S. District Court, District of South Carolina, all of which were filed on behalf of women who allegedly developed new-onset Type 2 diabetes due to their use of the statin medication. Plaintiffs assert, among other things, that the modifications made to the Lipitor label in response to the FDA’s 2012 mandate do not adequately warn patients about this potential complication.

Learn More about Filing a Lipitor Lawsuit

Bernstein Liebhard LLP is providing free legal reviews to post-menopausal women diagnosed with new-onset Type 2 diabetes following treatment with Lipitor. To discuss your case with a member of our legal staff today, please call (888) 994-5118.

  1. JACC (2011) “Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin”
  2. Archives of Internal Medicine (2012) “Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women’s Health Initiative”
  3. BMJ (2013) Risk of Incident Diabetes Among Patients Treated With Statins: Population Based Study”
  4. FDA (2012) “FDA Expands Advice on Statin Risks”
Last Modified: January 11, 2017

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content